Final answer:
Fetal cells in the mother's blood can be used for non-invasive prenatal testing (NIPT), which helps in detecting genetic abnormalities and determining the Rh status of the fetus without posing any risk to it.
Step-by-step explanation:
Fetal cells can escape into the mother's blood and are used in fetal testing, which provides a non-invasive method to assess the fetal genetic health. This testing is known as non-invasive prenatal testing (NIPT) and can detect chromosomal abnormalities such as Down syndrome, Edwards syndrome, and Patau syndrome, among others. Unlike amniocentesis, which involves drawing amniotic fluid and comes with a risk of miscarriage, NIPT poses no risk to the fetus since it requires only a blood sample from the mother. The presence of fetal DNA in maternal blood allows for this screening, and it is also useful in determining the Rh status of the fetus, thus helping in the management of potential Rh incompatibility.